Ironwood bulks up on digestive therapies with $1.15 billion VectivBio buy
By Raghav Mahobe (Reuters) -Ironwood Pharmaceuticals Inc said on Monday it would buy Switzerland-based drug developer VectivBio Holding AG for $1.15 billion, adding a promising treatment for digestive disorders to its portfolio.…
